NMR NOMURA HOLDINGS INC Insider Trading

Director Ogawa Shoji bought 238 NMR shares at $8.05; cluster of 2 other insiders also buying signals coordinated interest

Director Ogawa Shoji purchased 238 shares of Nomura Holdings at $8.05 on 2026-03-25, increasing his position from 38 to 276 shares (+616.1% net change). The transaction occurred within a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting coordinated or reinforcing insider interest in the security. The stock has since declined 20.6% from its 52-week high of $9.54 and trades at $7.58 currently—below the director's entry price—indicating the purchase preceded a downturn. This cluster buy activity during a period of price weakness at a $22.4B market-cap company warrants examination of what information or strategic assessment prompted multiple insiders to accumulate shares simultaneously.

Director Ishizuka Masahiro bought 238 NMR shares at $8.05 on 2026-03-25; stock down 20.6% from 52-week high. Cluster pattern: 2 other insiders also bought within 14 days.

Ishizuka Masahiro, a Director, purchased 238 shares at $8.05, increasing his holdings from 97 to 335 shares (+243.9%). This transaction occurred as NMR traded down 20.6% from its 52-week high of $9.54 and 17.3% below its 30-day average. Notably, 2 other insiders also purchased shares within the past 14 days, forming a cluster buy pattern that suggests alignment among company leadership during a period of price weakness. The significance of multiple directors accumulating equity simultaneously at depressed valuations warrants monitoring of their risk assessments and any forward-looking information they may possess.

Ozaki Yukiko bought 7 NMR shares at $8.05 on 2026-03-25; cluster of 3 insider buys in 14 days as stock down 18.9% from 52-week high

Ozaki Yukiko purchased 7 shares of Nomura Holdings at $8.05, increasing her stake by 14.5% to 62 shares post-transaction. The transaction occurs within a cluster pattern where 2 other insiders also bought within the past 14 days, suggesting coordinated interest at current valuations. The stock is trading at $7.74, down 18.9% from its 52-week high of $9.54 and down 14.5% over the past 30 days, creating a backdrop of near-term weakness. This cluster buy activity at depressed recent prices may reflect insider assessment of current valuations, though the modest share quantities limit the signal strength of any individual purchase.